The risk of adverse pregnancy outcomes in women who are overweight or obese by Athukorala, Chaturica et al.
RESEARCH ARTICLE Open Access
The risk of adverse pregnancy outcomes in
women who are overweight or obese
Chaturica Athukorala
1*, Alice R Rumbold
1,2, Kristyn J Willson
3, Caroline A Crowther
1
Abstract
Background: The prevalence of obesity amongst women bearing children in Australia is rising and has important
implications for obstetric care. The aim of this study was to assess the prevalence and impact of mothers being
overweight and obese in early to mid-pregnancy on maternal, peripartum and neonatal outcomes.
Methods: A secondary analysis was performed on data collected from nulliparous women with a singleton
pregnancy enrolled in the Australian Collaborative Trial of Supplements with antioxidants Vitamin C and Vitamin E
to pregnant women for the prevention of pre-eclampsia (ACTS). Women were categorized into three groups
according to their body mass index (BMI): normal (BMI 18.5-24.9 kg/m
2); overweight (BMI 25-29.9 kg/m
2) and;
obese (BMI 30-34.9 kg/m
2). Obstetric and perinatal outcomes were compared by univariate and multivariate
analyses.
Results: Of the 1661 women included, 43% were overweight or obese. Obese women were at increased risk of
pre-eclampsia (relative risk (RR) 2.99 [95% confidence intervals (CI) 1.88, 4.73], p < 0.0001) and gestational diabetes
(RR 2.10 [95%CI 1.17, 3.79], p = 0.01) compared with women with a normal BMI. Obese and overweight women
were more likely to be induced and require a caesarean section compared with women of normal BMI (induction -
RR 1.33 [95%CI 1.13, 1.57], p = 0.001 and 1.78 [95%CI 1.51, 2.09], p < 0.0001, caesarean section - RR 1.42 [95%CI
1.18, 1.70], p = 0.0002 and 1.63 [95%CI 1.34, 1.99], p < 0.0001). Babies of women who were obese were more likely
to be large for gestational age (LFGA) (RR 2.08 [95%CI 1.47, 2.93], p < 0.0001) and macrosomic (RR 4.54 [95%CI 2.01,
10.24], p = 0.0003) compared with those of women with a normal BMI.
Conclusion: The rate of overweight and obesity is increasing amongst the Australian obstetric population. Women
who are overweight and obese have an increased risk of adverse pregnancy outcomes. In particular, obese women
are at increased risk of gestational diabetes, pregnancy induced hypertension and pre-eclampsia. Effective
preventative strategies are urgently needed.
Trial Registration: Current Controlled Trials ISRCTN00416244
Background
In Australia, the incidence of overweight and obesity is
increasing in both women and men and amongst all age
groups [1]. Between 2004 and 2005, approximately 15%
of women aged 25 to 34 years of age were obese [1].
This age bracket has the highest fertility rate and hence
maternal overweight and obesity has significant implica-
tions for the provision of obstetric care [1].
Mothers who are overweight or obese during preg-
nancy and childbirth, as measured by increasing maternal
body mass index (BMI), are known to be at risk of signifi-
cant antenatal, intrapartum, postpartum and neonatal
complications. Antenatal complications include recurrent
miscarriage, congenital malformations, pregnancy
induced hypertension (PIH), pre-eclampsia, gestational
diabetes mellitus (GDM) and venous thromboembolism
[2-5]. Overweight and obese women are more likely to be
induced and require a caesarean [6,7]. Infants of over-
weight and obese mothers are often macrosomic and
require prolonged hospital admissions [6,7].
It has been estimated that the cost of prenatal care in
overweight women exceeds that of normal-weight con-
trol subjects by 5.4 to 16.2-fold depending on the degree
of obesity [8]. In addition, children who are large for
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exposed to an intrauterine environment of either diabetes
or maternal obesity, are at increased risk of developing a
metabolic syndrome, thus perpetuating the cycle of obe-
sity and insulin resistance in subsequent generations [9].
The aim of this study was to assess the prevalence and
impact of mothers being overweight and obese in early
to mid-pregnancy on maternal, peripartum and neonatal
outcomes in a sample of nulliparous women. An
additional aim was to identify maternal characteristics
associated with a high risk of being overweight and obese.
Methods
1877 women were enrolled in the Australian Collabora-
tive Trial of Supplements with antioxidants Vitamin C
and Vitamin E to pregnant women for the prevention of
pre-eclampsia (ACTS), a multi-centre randomised pla-
cebo controlled trial of antioxidant supplements for the
prevention of perinatal complications [10]. The study
recruited nulliparous women with a singleton pregnancy
between 14 and 22 weeks gestation who were normo-
tensive at the first measurement in pregnancy and again
at trial entry. Of these women, 1661 (88%) had a BMI
recorded at first antenatal visit and were included in the
present study. Study recruitment took place between
December 2001 and January 2005.
Women were randomised through a central telephone
randomization service to either the vitamin (100 mg
vitamin C and 400 mg vitamin E daily) or placebo
group (four tablets of microcrystalline cellulose daily).
The primary results of this trial have been published
previously [10]. The trial found no overall difference in
perinatal outcomes between antioxidant and vitamin
groups, therefore data from both groups were combined
in the analyses for the current study. Women were cate-
gorized into three groups according to their body mass
index (BMI) which was calculated using hospital data
from their first antenatal visit: normal (BMI 18.5-24.9
kg/m
2); overweight (BMI 25-29.9 kg/m
2) and; obese
(BMI greater than 30 kg/m
2).
Data collection
Sociodemographic variables were collected either from
women’s medical records or self-completed question-
naires at trial entry and included: maternal age, ethni-
city, body mass index, social-economic status as
measured by Socio-Economic Indexes for Area (SEIFA)
score [11], maternal education, smoking status and
blood pressure at trial entry.
Outcome variables
Pregnancy outcomes assessed included: maternal adverse
outcome (a composite outcome defined as any of the
following until six weeks postpartum: death, pulmonary
oedema, eclampsia, stroke, thrombocytopenia, renal
insufficiency, respiratory arrest, placental abruption,
abnormal liver function, preterm prelabour rupture of
membranes, major postpartum haemorrhage, postpar-
tum pyrexia, pneumonia, deep-vein thrombosis, or pul-
monary embolus requiring anticoagulant therapy);
pregnancy induced hypertension (PIH); pre-eclampsia
(defined as systolic blood pressure ≥ 140 mmHg or dia-
stolic blood pressure [Korotkoff V] ≥ 90 mmHg on at
least two occasions four or more hours apart, or both
arising after 20 weeks’ gestation and one or more of the
following: proteinuria, renal insufficiency, liver disease,
neurological problems, haematologic disturbances, or
fetal growth restriction) [12]; antenatal hospitalisation;
preterm prelabour rupture of the membranes; induction
of labour; mode of birth; postnatal complications such
as postpartum haemorrhage and infection; and length of
hospital stay.
Neonatal outcomes included a composite outcome of
death or infant adverse outcome defined as: fetal or
perinatal death, birthweight < 3
rd centile for gestational
age, severe respiratory distress syndrome, chronic lung
disease, intraventricular hemorrhage grade 3 or 4, cystic
periventricular leukomalacia, retinopathy of prematurity
grade 3 or 4, necrotizing enterocolitis, 5 minute Apgar
score < 4, seizures before 24 hours of age or requiring 2
or more drugs to control, hypotonia for ≥ 2h o u r s ,s t u -
por, decreased response to pain or coma, tube feeding
for ≥ 4 days, care in the neonatal intensive care unit
(NICU) > 4 days, or use of ventilation for ≥ 24 hours
[13,14]; as well as: gestational age at birth; preterm birth
(< 37 weeks);5 minute Apgar score < 7; infant body size
at birth (weight, length and head circumference); small
and large-for-gestational age (defined as a birth weight
below the 10
th percentile or above 90
th percentile for
gestation according to fetal sex on standardized birth-
weight charts, respectively) [15]; macrosomia (defined as
birthweight ≥ 4.5 kg); admission to NICU or neonatal
nursery; respiratory distress syndrome; and length of
hospital stay.
Statistical analysis
Statistical analysis was carried out using SAS soft-
ware, version 9.1. Binary variables were analysed
using log-binomial regression with results expressed
as relative risks and 95% confidence intervals. Con-
tinuous variables, if normally distributed, were ana-
lysed using analysis of variance and presented as
risk-adjusted mean differences with 95% confidence
intervals. Non-parametric tests were used for skewed
data. A p value of < 0.05 was considered to indicate
statistical significance. The group of women with a
normal BMI was used as the reference category for
all analyses.
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Demographics
Of the 1661 women included in the study, 943 (57%)
had a normal BMI, 446 (27%) were overweight and 272
( 1 6 % )w e r eo b e s ea tf i r s ta n t e n a t a lv i s i t( T a b l e1 ) .N o
women recorded a BMI less than 18.5. The mean gesta-
tional age at trial entry was 17.2 weeks in all three
groups.
Overweight and obese women had significantly higher
systolic blood pressure readings at trial entry compared
with women with a normal BMI (Mean Difference (MD)
3.6 [95%CI 2.5,4.8], p < 0.0001 and MD 7.8 [95%CI
6.4,9.2], p < 0.0001 respectively). Similar findings were
found for diastolic blood pressure readings at trial entry
(MD 2.5 [95%CI 1.6,3.4], p < 0.0001 and MD 6.1 [95%
CI 5.1,7.2], p < 0.0001 respectively) (Table 1).
Overweight women were more likely to be caucasian
and less likely to be asian than normal weight women
(RR 1.03 [95%CI 1.00, 1.05], p = 0.03 and RR 0.33 [95%
CI 0.14, 0.78], p = 0.01 respectively). Obese women
were less likely to be asian than women with a normal
BMI (RR 0.36 [95%CI 0.13, 1.01], p = 0.05) (Table 1).
Overweight and obese women were more likely to
have achieved a TAFE or equivalent education than
healthy weight women (RR 1.26 [95%CI 1.03, 1.53], p =
0.02 and RR 1.32 [95%CI 1.06, 1.66], p = 0.01). Obese
women were less likely to go to university than healthy
weight women (RR 0.71 [95%CI 0.57,0.89], p = 0.003)
(Table 1).
Obese women were more likely to be of low socio-
economic level compared with normal BMI women (RR
1.50 [95%CI 1.23, 1.83], p = 0.0001). Accordingly, obese
w o m e nw e r el e s sl i k e l yt ob eo fh i g hS o c i o - E c o n o m i c
level compared with women with a normal BMI (RR
0.67 [95%CI 0.52,0.84], p = 0.001) (Table 1).
Pregnancy outcomes
Obese women were at higher risk of developing pre-
eclampsia compared with women with a normal BMI
(RR 2.99 [95%CI 1.88, 4.73)], p < 0.0001). They were
more likely to be hospitalised for hypertension than
women with a normal BMI (RR 2.87 [95%CI 1.70, 4.84],
p = 0.0001) (Table 2). Obese women received more
magnesium sulphate and antihypertensives than women
with a normal BMI (RR 2.97 [95%CI 1.01, 8.77], p =
0.05 and RR 3.31 [95%CI 1.85, 5.93], p = 0.0001 respec-
tively) (Table 2).
Compared to women with a normal BMI, overweight
and obese women had an increased risk of pregnancy-
induced hypertension (PIH) than women with a normal
BMI (RR 1.94 [95%CI 1.43, 2.65], p < 0.0001 and RR
3.19 [95%CI 2.36, 4.30], p < 0.0001 respectively) and
severe PIH (RR 2.76 [95%CI 1.35, 5.64], p = 0.01 and
RR 4.00 [95%CI 1.93, 8.30], p = 0.0002 respectively)
(Table 2).
Obese women were at higher risk of developing gesta-
tional diabetes than women with a normal BMI (RR
2.10 [95%CI 1.17, 3.79], p = 0.01) (Table 2).
Table 1 Demographics of women with normal BMI compared with overweight and obese women
Characteristic Normal
n = 943
(%)
Overweight
n = 446
(%)
Obese
n = 272
(%)
Overweight
vs. Normal
[95% CI]
p value Obese
vs. Normal
[95% CI]
p value
Age (years)
a 26.7 ± 5.9 26.8 ± 5.6 26.4 ± 5.1 0.2 [-0.5,0.8] 0.61 -0.3 [-1.1,0.5] 0.44
GA Entry (weeks)
a 17.2 ± 2.4 17.2 ± 2.4 17.2 ± 2.5 -0.04 [-0.3,0.2] 0.77 -0.05 [-0.4,0.3] 0.77
Systolic BP at Trial Entry (mm Hg)
a 108.2 ± 10.2 111.8 ± 9.9 116.0 ± 9.7 3.6 [2.5,4.8] < 0.0001 7.8 [6.4,9.2] < 0.0001
Diastolic BP at Trial Entry (mm Hg)
a 63.8 ± 7.6 66.3 ± 7.9 70.0 ± 7.8 2.5 [1.6,3.4] < 0.0001 6.1 [5.1,7.2] < 0.0001
Race
Caucasian 885 (93.8) 430 (96.4) 261 (96.0) 1.03 [1.00,1.05] 0.03 1.02 [0.99,1.05] 0.14
Asian 38 (4.0) 6 (1.3) 4 (1.5) 0.33 [0.14,0.78] 0.01 0.36 [0.13,1.01] 0.05
Other 20 (2.1) 10 (2.2) 7 (2.6) 1.06 [0.50,2.24] 0.88 1.21 [0.52,2.84] 0.66
Education
Secondary or lower 394 (42.8) 182 (41.8) 124 (46.1) 0.98 [0.86,1.12] 0.74 1.08 [0.93,1.25] 0.33
Diploma or equiv 199 (21.6) 118 (27.1) 77 (28.6) 1.26 [1.03,1.53] 0.02 1.32 [1.06,1.66] 0.01
University 328 (35.6) 135 (31.0) 68 (25.3) 0.87 [0.74,1.03] 0.10 0.71 [0.57,0.89] 0.003
Socio-economic index
Low SEI 222 (23.5) 112 (25.1) 96 (35.3) 1.07 [0.88,1.30] 0.52 1.50 [1.23,1.83] 0.0001
Low-Mid SEI 155 (16.4) 81 (18.2) 44 (16.2) 1.10 [0.87,1.41] 0.42 0.98 [0.72,1.34] 0.92
Mid-High SEI 248 (26.3) 119 (26.7) 71 (26.1) 1.01 [0.84,1.22] 0.88 0.99 [0.79,1.25] 0.95
High SEI 318 (33.7) 134 (30.0) 61 (22.4) 0.89 [0.75,1.05] 0.18 0.67 [0.52,0.84] 0.001
Smoking 198 (21.0) 94 (21.1) 51 (18.8) 1.00 [0.81,1.25] 0.97 0.89 [0.68,1.18] 0.42
aValue is mean ± standard deviation and the comparison is mean difference [95% CI].
BP, blood pressure; SEI, Socio-economic Index.
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women were more likely to be induced than women
with a normal BMI (RR 1.33 [95%CI 1.13, 1.57], p =
0.001 and RR 1.78 [95%CI 1.51, 2.09], p < 0.0001 respec-
tively) (Table 3). The indication was more commonly
hypertension in overweight and obese women compared
to women with a normal BMI (RR 1.93 [95%CI 1.21,
3.08], p = 0.01 and RR 3.96 [95%CI 2.57, 6.11], p <
0.0001 respectively). Overweight and obese women were
more frequently induced for diabetes related complica-
tions than women with a normal BMI (RR 4.93 [95%CI
1.28, 18.99], p = 0.02 and RR 11.6 [95%CI 3.20, 41.69], p
= 0.0002 respectively) (Table 3).
Compared with women with a normal BMI, over-
weight and obese women were more likely to undergo a
caesarean section overall (RR 1.42 [95%CI 1.18, 1.70], p
= 0.0002 and RR 1.63 [95%CI 1.34, 1.99] p < 0.0001
respectively) and have an emergency caesarean section
(RR 1.48 [95%CI 1.19, 1.83], p = 0.0004 and 1.77 [95%CI
1.40, 2.23], p < 0.0001 respectively) (Table 3). Relating
to the indication for caesarean section, obese women
were more likely to require a caesarean section for pre-
eclampsia than women with a normal BMI (RR 3.47
[95%CI 1.39, 8.65], p = 0.01), overweight and obese
women were more likely to require a caesarean section
for fetal distress than women with a normal BMI (RR
1.40 [95%CI 1.03, 1.91], p = 0.03 and RR 1.71 [95%CI
1.23, 2.40], p = 0.002) and overweight and obese women
were more likely to require a caesarean section for fail-
ure to progress than women with a normal BMI (RR
Table 2 Pregnancy complications among women with normal BMI compared with overweight and obese women
Characteristic Normal
n = 943
(%)
Overweight
n = 446
(%)
Obese
n = 272
(%)
Overweight
vs. Normal
[95% CI]
p value Obese
vs. Normal
[95% CI]
p value
Maternal Death or Adverse Outcome 68 (7.2) 43 (9.6) 28 (10.3) 1.34 [0.93,1.93] 0.12 1.43 [0.94,2.17] 0.10
Pre-Eclampsia 36 (3.8) 25 (5.6) 31 (11.4) 1.47 [0.89,2.42] 0.13 2.99 [1.88,4.73] < 0.0001
Pregnancy Induced Hypertension 74 (7.8) 68 (15.2) 68 (25.0) 1.94 [1.43,2.65] < 0.0001 3.19 [2.36,4.30] < 0.0001
Severe PIH 13 (1.4) 17 (3.8) 15 (5.5) 2.76 [1.35,5.64] 0.01 4.00 [1.93,8.30] 0.0002
Antenatal hospitalisation hypertension 29 (3.1) 19 (4.3) 24 (8.8) 1.39 [0.79,2.44] 0.26 2.87 [1.70,4.84] 0.0001
MgSO4 used 7 (0.7) 4 (0.9) 6 (2.2) 1.21 [0.36,4.11] 0.76 2.97 [1.01,8.77] 0.05
2 hr OGTT ≥ 7.8 mmol/L 28 (3.0) 16 (3.6) 17 (6.3) 1.21 [0.66,2.21] 0.54 2.10 [1.17,3.79] 0.01
Antihypertensives 22 (2.3) 17 (3.8) 21 (7.7) 1.63 [0.88,3.05] 0.12 3.31 [1.85,5.93] 0.0001
PPROM 23 (2.4) 16 (3.6) 8 (2.9) 1.47 [0.78,2.76] 0.23 1.21 [0.55,2.67] 0.64
PIH, pregnancy induced hypertension; MgSO4, magnesium sulphate; OGTT, oral glucose tolerance test; PPROM, preterm prelabour rupture of membranes.
Table 3 Pregnancy complications among women with normal BMI compared with overweight and obese women
Outcome Normal
n = 943
(%)
Overweight
n = 446
(%)
Obese
n = 272
(%)
Overweight
vs. Normal
[95% CI]
p value Obese
vs. Normal
[95% CI]
p value
Chorioamnionitis requiring antibiotics 10 (1.1) 3 (0.7) 3 (1.1) 0.63 [0.18,2.29] 0.49 1.04 [0.29,3.75] 0.95
Induction 250 (26.5) 157 (35.2) 128 (47.1) 1.33 [1.13,1.57] 0.001 1.78 [1.51,2.09] < 0.0001
Induction for hypertension 35 (3.7) 32 (7.2) 40 (14.7) 1.93 [1.21,3.08] 0.01 3.96 [2.57,6.11] < 0.0001
Induction for GDM/IDDM 3 (0.3) 7 (1.6) 10 (3.7) 4.93 [1.28,18.99] 0.02 11.6 [3.20,41.69] 0.0002
Caesarean Section 210 (22.3) 141 (31.6) 99 (36.4) 1.42 [1.18,1.70] 0.0002 1.63 [1.34,1.99] < 0.0001
Elective Caesarean Section 51 (5.4) 30 (6.7) 18 (6.6) 1.24 [0.80,1.92] 0.33 1.22 [0.73,2.06] 0.45
Emergency Caesarean Section 159 (16.9) 111 (24.9) 81 (29.8) 1.48 [1.19,1.83] 0.0004 1.77 [1.40,2.23] < 0.0001
CS for Pre-Eclampsia 9 (1.0) 3 (0.7) 9 (3.3) 0.70 [0.19,2.59] 0.60 3.47 [1.39,8.65] 0.01
CS for Fetal Distress 89 (9.4) 59 (13.2) 44 (16.2) 1.40 [1.03,1.91] 0.03 1.71 [1.23,2.40] 0.002
CS for Chorioamnionitis 2 (0.2) 0 (0.0) 1 (0.4) –– ––
CS for CPD 6 (0.6) 6 (1.3) 5 (1.8) 2.11 [0.69,6.52] 0.19 2.89 [0.89,9.39] 0.08
CS for Failure to Progress 83 (8.8) 59 (13.2) 44 (16.2) 1.50 [1.10,2.06] 0.01 1.84 [1.31,2.58] 0.0004
Length of Stay (days)
a 3.0 ± 1.6 3.3 ± 2.1 3.4 ± 1.7 0.3 [0.1,0.5] 0.01 0.3 [0.1,0.6] 0.01
Major Post Partum Haemorrhage 20 (2.1) 12 (2.7) 10 (3.7) 1.27 [0.63,2.57] 0.51 1.73 [0.82,3.66] 0.15
Antibiotics post partum 132 (14.0) 81 (18.2) 48 (17.6) 1.30 [1.01,1.67] 0.04 1.26 [0.93,1.70] 0.13
Antibiotics for Wound Infection 10 (1.1) 6 (1.3) 8 (2.9) 1.27 [0.46,3.47] 0.64 2.77 [1.11,6.96] 0.03
aValue is mean ± standard deviation and the comparison is mean difference [95% CI].
GDM, gestational diabetes mellitus; IDDM, Insulin-Dependent Diabetes Mellitus; CS, caesarean section; IUGR, intrauterine growth restriction; CPD, cephalopelvic
disproportion.
Athukorala et al. BMC Pregnancy and Childbirth 2010, 10:56
http://www.biomedcentral.com/1471-2393/10/56
Page 4 of 81.50 [95%CI 1.10, 2.06], p = 0.01 and RR 1.84 [95%CI
1.31, 2.58], p = 0.0004 respectively) (Table 3).
Overweight women were more likely to require anti-
biotics postpartum compared to women with a normal
BMI (RR 1.30 [95%CI 1.01, 1.67], p = 0.04) (Table 3).
Obese women were more likely than women with a nor-
mal BMI to require antibiotics for a wound infection
(RR 2.77 [95%CI 1.11, 6.96], p = 0.03) (Table 3).
Mean birth weight of babies born to overweight and
obese mothers were significantly greater than babies
born to women with a normal BMI (MD 64.4 ([95%CI
-0.9, 129.8], p = 0.05 and MD 99.7 [95%CI 21.3, 178.2],
p = 0.01 respectively) (Table 4). The birth weight Z-
score of babies born to overweight and obese mothers
was significantly greater than that of babies born to
mother with a normal BMI (MD 0.10 [95% CI -0.00,
0.21], p = 0.06 and MD 0.24 [95% CI 0.11, 0.37], p =
0.0003 respectively) (Table 4). Babies of obese mothers
were more likely to be large for gestational age (LFGA)
compared with babies of women with a normal BMI
(RR 2.08 [95%CI 1.47, 2.93], p < 0.0001) (Table 4).
Babies of obese mothers were more likely to be macro-
somic than those of mothers with a normal (RR 4.54
[95%CI 2.01, 10.24], p = 0.0003) (Table 4).
Babies of overweight and obese mothers had a greater
head circumference when compared with babies of
mothers with a normal BMI (MD 0.30 [95%CI 0.1, 0.5],
p = 0.01 and MD 0.34 [95%CI 0.1, 0.6], p = 0.01
respectively) (Table 4). Accordingly, these finding were
similar for birth head circumference Z-scores (MD 0.18
[95%CI 0.05, 0.31], p = 0.01 and MD 0.28 [95%CI 0.13,
0.44], p = 0.0003 respectively) (Table 4).
Discussion
Our study found that increasing maternal BMI was
associated with adverse health outcomes for both the
mother and her baby. These findings are consistent with
those of previous studies in showing an association
between increasing maternal BMI and an increased risk
of hypertensive disorders of pregnancy, GDM, induction
of labour, caesarean section, longer length of maternal
stay in hospital and increased birth weight [4-7]
T h ep r e v a l e n c eo fm a t e r n a lo v e r w e i g h ta n do b e s i t y
found in this study (43%) is higher than that reported in
one other study of Australian women giving birth in
Queensland between 1998 and 2002, which reported
that 34% of women were overweight or obese[7].
Recruitment for the ACTS trial took place between
2001 and 2005, therefore the higher prevalence seen in
this study is consistent with national data indicating that
overweight and obesity is increasing across the entire
Australian population [1].
Our study found that Caucasian women were more
likely to be overweight and obese than Asian women.
The relationship of increasing BMI and its associated
complications varies between ethnic groups. Asian
Table 4 Clinical outcomes among babies born to women with normal BMI compared to overweight and obese women
Outcome Normal
n = 943
(%)
Overweight
n = 446
(%)
Obese
n = 272
(%)
Overweight
vs. Normal
[95% CI]
p value Obese
vs. Normal
[95% CI]
p value
Infant Death or Adverse Outcome 97 (10.3) 50 (11.2) 28 (10.3) 1.09 [0.79,1.50] 0.60 1.00 [0.67,1.49] 1.00
Death Pre-Discharge 12 (1.3) 6 (1.3) 8 (2.9) 1.06 [0.40,2.80] 0.91 2.31 [0.95,5.60] 0.06
Liveborns n = 933 (%) n = 441 (%) n = 266 (%)
GA at Delivery (weeks)
b 40.0 (39.0-41.0) 40.1 (39.0-41.0) 40.0 (38.9-41.0) – 0.34 – 0.72
Preterm birth (GA < 37 weeks) 59 (6.3) 27 (6.1) 21 (7.8) 0.97 [0.62,1.51] 0.90 1.24 [0.77,2.01] 0.37
Apgar at 5 minutes < 4 3 (0.3) 1 (0.2) 1 (0.4) 0.71 [0.07,6.76] 0.76 1.17 [0.12,11.19] 0.89
Admission to NICU 29 (3.1) 15 (3.4) 9 (3.4) 1.09 [0.59,2.02] 0.77 1.09 [0.52,2.27] 0.82
RDS 3 (0.3) 5 (1.1) 3 (1.1) 3.53 [0.85,14.69] 0.08 3.51 [0.71,17.28] 0.12
Birth Weight (g)
a 3376 ± 573.7 3440 ± 553.5) 3476 ± 630.8 64.4 [-0.9,129.8] 0.05 99.7 [21.3,178.2] 0.01
SFGA (Birthweight < 10
th percentile) 91 (9.8) 35 (7.9) 20 (7.5) 0.81 [0.56,1.18] 0.28 0.77 [0.48,1.23] 0.27
LFGA (Birthweight ≥ 90
th percentile) 76 (8.1) 48 (10.9) 45 (16.9) 1.34 [0.95,1.88] 0.10 2.08 [1.47,2.93] < 0.0001
Birthweight ≥ 4.5 kg 10 (1.1) 9 (2.0) 13 (4.8) 1.91 [0.78,4.67] 0.16 4.54 [2.01,10.24] 0.0003
Births (excluding fetal losses) n = 940 (%) n = 443 (%) n = 269 (%)
Birth Length (cm)
a 50.4 ± 3.1 50.6 ± 3.0 50.5 ± 2.9 0.21 [-0.1,0.6] 0.24 0.17 [-0.3,0.6] 0.43
Birth Head Circumference (cm)
a 34.4 ± 1.9 34.7 ± 1.8 34.7 ± 1.9 0.30 [0.1,0.5] 0.01 0.34 [0.1. 0.6] 0.01
Birth Weight Z-Score
a -0.08 ± 0.89 0.02 ± 0.94 0.16 ± 1.08 0.10 [-0.00,0.21] 0.06 0.24 [0.11,0.37] 0.0003
Birth Length Z-Score
a 0.01 ± 1.18 0.08 ± 1.19 0.11 ± 1.16 0.08 [-0.06,0.21] 0.27 0.10 [-0.06,0.27] 0.21
Birth Head Circumference Z-Score
a -0.21 ± 1.10 -0.03 ± 1.13 0.07 ± 1.16 0.18 [0.05,0.31] 0.01 0.28 [0.13,0.44] 0.0003
aValue is mean ± standard deviation and the comparison is mean difference [95% CI].
bValue is median (Interquartile range).
SFGA, small for gestational age; NICU, neonatal intensive care unit; RDS, respiratory distress syndrome, GA, gestational age;
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any given BMI, resulting in different suggested BMI cut-
off points for these populations [16]. We used the same
BMI cut-off points for all races included in our study
and hence Asian women are more likely to have been
allocated to the normal BMI group.
W ef o u n dt h a to v e r w e i g h ta n do b e s ew o m e nw e r e
more likely to achieve a TAFE or equivalent education
than healthy weight women and that obese women were
less likely to obtain a university education than healthy
weight women. Furthermore, obese women were more
likely to be of low socio-economic level compared with
women in the normal BMI group. This is in keeping
with findings from a large, population-based study con-
ducted in Australia that concluded that lower educa-
tional attainment was consistently predictive of obesity
in each sex and that increasing income decreased the
risk of obesity in women [17].
The findings of our study confirm the association
between increasing BMI and the risk of PIH
[4,6,7,18,19]. Despite detecting an increase in the risk of
pre-eclampsia amongst obese women when compared
with women with a normal wei g h t ,w ew e r eu n a b l et o
detect a difference between the overweight and normal
weight groups; however there did appear to be a trend
towards increasing risk in the overweight group. A pre-
vious study has demonstrated a linear relationship
between increasing BMI and pre-eclampsia amongst
both overweight and obese women which is more pro-
nounced amongst nulliparous women [19]. It is esti-
mated that each one-unit increase in BMI among
nulliparous women confers a 7% increase in risk for
pre-eclampsia (95%CI 1.06, 1.08) and a 6% increase in
risk for early pre-eclampsia (95%CI 1.05, 1.08) (13).
Our study found that obese women were at increased
risk of developing gestational diabetes compared with
women with a normal weight. We did not detect a dif-
ference in risk between the overweight and normal
weight groups. A recent meta-analysis exploring the
association between GDM and BMI estimated that the
risk of developing GDM is two and four times higher
among overweight and obese women respectively com-
pared with normal-weight pregnant women [20].
Although our results showed an increased incidence of
pre-eclampsia and GDM among obese women com-
pared to normal weight women, it is likely that we were
unable to detect the less pronounced variation in inci-
dence between overweight women and their healthy
counterparts due to inadequate statistical power result-
ing from small numbers of women in the overweight
and obese groups.
The increased incidence of antenatal medical compli-
cations seen in overweight and obese mothers in our
study contributed to increased rates of induction
compared with women with a normal BMI. Overweight
and obese mothers had higher rates of emergency cae-
sarean for indications including pre-eclampsia, fetal dis-
tress and failure to progress. We did not see an increase
in caesarean section for cephalo-pelvic disproportion
(CPD) among overweight and obese mothers, as has
been reported in previous research [21]. CPD in over-
weight and obese patients has been described as a con-
sequence of increased fetal size and soft-tissue dystocia
as a result of adipose tissue accumulation in the mater-
nal pelvis [22].
Postpartum, women who are overweight and obese are
more likely to suffer from infective complications and
haemorrhage than women with a healthy weight
[23-26]. In keeping with this, we found that women who
were overweight were more likely to receive antibiotics
postpartum compared with women with a normal
w e i g h ta n dt h a to b e s ew o m e nw e r em o r el i k e l yt o
receive antibiotics for wound infection compared with
normal weight women. The increase in PPH seen with
increasing BMI in other studies is thought to be con-
tributed to by the higher rates of caesarean section and
hence higher risk of haemorrhage [26]. Although
increased haemorrhage rates amongst obese nulliparous
women have been described [26], our study, which
included only nulliparous women, did not find differ-
ences in risk of PPH.
There were no cases of maternal death in our sample,
which was expected given our sample size and the low
maternal mortality rate seen in the Australian obstetric
population. The most recent report on maternal deaths
in Australia between 1997 and 1999 found obstetric
haemorrhage to be the leading direct cause of maternal
mortality which was postulated to be a result of increas-
ing caesarean rates [27]. Thromboembolism and hyper-
tensive disorders were also identified as major
contributors. Increasing BMI is associated with an
increased risk of all three of these factors and therefore
it is possible that with increasing obesity amongst preg-
nant women, a trend towards increasing maternal mor-
tality may emerge. As yet, in Australia, state-based
routine perinatal data collections do not include mater-
nal BMI thus inhibiting an accurate assessment of the
impact of weight on maternal death.
Consistent with the established association between
increasing maternal BMI and increasing birth weight,
our results showed a correlation with increasing head
circumference [6,7]. Increased rates of vaginal birth
among normal weight women may have contributed to
this result as moulding of the baby’s skull during vaginal
delivery would have resulted in a smaller head circum-
ference. Specific anthropomorphic patterns in offspring
of diabetic mothers have been observed [28] however
other measures of body size a n ds k i nf o l dt h i c k n e s s
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Page 6 of 8were not measured in this study. We did not collect
data on rates of shoulder dystocia but increased rates
amongst obese women as a result of soft-tissue dystocia
and fetal macrosomia have been reported [24].
Although the sample size for this study was too small
to assess the effect of increasing BMI on rare outcomes,
we used a composite endpoint for maternal and infant
serious outcome that included morbidities such as rates
of venous thromboembolism, chorioamnionitis, NICU
admission, neonatal death, stillbirth and infant death.
Our study did not find a statistically significant differ-
ence in this composite endpoint, however increased
rates of mortality and morbidity among overweight and
obese mothers have been demonstrated by previous stu-
dies [5,7,29,30]. Our study did not see a correlation
between increasing BMI and preterm birth which has
previously been identified and thought to be a result of
higher rates of early induction and preterm prelabour
rupture of membranes (PPROM) [30].
Conclusions
The results of our study add to the emerging body of
literature on the consequences of mothers being over-
weight and obese during pregnancy and childbirth.
Increased maternal and neonatal morbidity results in
the increased utilisation of resources at a significant cost
to the community. There is an urgent need to establish
effective preventative strategies, both prior to pregnancy
and during pregnancy, based on evidence from high
quality randomised controlled trials.
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